JNBA Financial Advisors grew its position in shares of Amazon.com, Inc. (NASDAQ:AMZN) by 2.9% in the 4th quarter, according ...
Kepler Capital analyst Christophe dombu maintained a Buy rating on MaaT Pharma (MAAT – Research Report) on March 12 and set a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback